CDK1 抑制可减少血管钙化中内皮细胞的成骨作用。

CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification.

机构信息

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

The Molecular Biology Institute at UCLA, Los Angeles, California, USA.

出版信息

JCI Insight. 2024 Mar 8;9(5):e176065. doi: 10.1172/jci.insight.176065.

Abstract

Vascular calcification is a severe complication of cardiovascular diseases. Previous studies demonstrated that endothelial lineage cells transitioned into osteoblast-like cells and contributed to vascular calcification. Here, we found that inhibition of cyclin-dependent kinase (CDK) prevented endothelial lineage cells from transitioning to osteoblast-like cells and reduced vascular calcification. We identified a robust induction of CDK1 in endothelial cells (ECs) in calcified arteries and showed that EC-specific gene deletion of CDK1 decreased the calcification. We found that limiting CDK1 induced E-twenty-six specific sequence variant 2 (ETV2), which was responsible for blocking endothelial lineage cells from undergoing osteoblast differentiation. We also found that inhibition of CDK1 reduced vascular calcification in a diabetic mouse model. Together, the results highlight the importance of CDK1 suppression and suggest CDK1 inhibition as a potential option for treating vascular calcification.

摘要

血管钙化是心血管疾病的严重并发症。先前的研究表明内皮谱系细胞向成骨样细胞转化并促进血管钙化。在这里,我们发现抑制细胞周期蛋白依赖性激酶(CDK)可阻止内皮谱系细胞向成骨样细胞转化并减少血管钙化。我们发现,在钙化动脉中的内皮细胞(EC)中,CDK1 被强烈诱导,并且显示出 EC 特异性基因缺失 CDK1 可减少钙化。我们发现限制 CDK1 诱导 E-二十六特异性序列变体 2(ETV2),这负责阻止内皮谱系细胞进行成骨分化。我们还发现抑制 CDK1 可减少糖尿病小鼠模型中的血管钙化。总之,这些结果强调了抑制 CDK1 的重要性,并表明抑制 CDK1 可能是治疗血管钙化的一种潜在选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb3/10972591/8da13acd1d95/jciinsight-9-176065-g083.jpg

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索